Epistaxis risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(19 intermediate revisions by 7 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Epistaxis}}
{{Epistaxis}}
Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.


'''Editor in Chief''': [[User:Ludi|Liudvikas Jagminas, M.D., FACEP]] [mailto:LJagminas@mhri.org] Phone: 401-729-2419
 
== Overview ==
'''Editor in Chief''': [[User:C Michael Gibson|C. Michael Gibson, M.S., M.D.]] [[Mailto:charlesmichaelgibson@gmail.com|[1]]], {{AE}} [[User:Amir Bagheri|Amir Behzad Bagheri, M.D.]] {{Jose}}
==Overview==
The most common risk factor of [[epistaxis]] is [[trauma]]. Other risk factors include [[coagulopathies]], [[infections]] and [[vascular abnormalities]]. It can occur spontaneously. Childhood and senility are unchangeable risk factors.
 
==Risk Factors==
==Risk Factors==
* Occasionally, nosebleeds may indicate other disorders such as bleeding disorders or high blood pressure.
 
* Frequent nosebleeds may also be a sign of hereditary hemorrhagic telangiectasia (also called HHT or Osler-Weber-Rendu syndrome).
*Trauma is the most common risk factor of epistaxis. Childhood and senility are unchangeable risk factors. Other risk factors are:<ref name="TunkelAnne2020">{{cite journal|last1=Tunkel|first1=David E.|last2=Anne|first2=Samantha|last3=Payne|first3=Spencer C.|last4=Ishman|first4=Stacey L.|last5=Rosenfeld|first5=Richard M.|last6=Abramson|first6=Peter J.|last7=Alikhaani|first7=Jacqueline D.|last8=Benoit|first8=Margo McKenna|last9=Bercovitz|first9=Rachel S.|last10=Brown|first10=Michael D.|last11=Chernobilsky|first11=Boris|last12=Feldstein|first12=David A.|last13=Hackell|first13=Jesse M.|last14=Holbrook|first14=Eric H.|last15=Holdsworth|first15=Sarah M.|last16=Lin|first16=Kenneth W.|last17=Lind|first17=Meredith Merz|last18=Poetker|first18=David M.|last19=Riley|first19=Charles A.|last20=Schneider|first20=John S.|last21=Seidman|first21=Michael D.|last22=Vadlamudi|first22=Venu|last23=Valdez|first23=Tulio A.|last24=Nnacheta|first24=Lorraine C.|last25=Monjur|first25=Taskin M.|title=Clinical Practice Guideline: Nosebleed (Epistaxis)|journal=Otolaryngology–Head and Neck Surgery|volume=162|issue=1_suppl|year=2020|pages=S1–S38|issn=0194-5998|doi=10.1177/0194599819890327}}</ref>
* Blood thinners such as Coumadin, Plavix, or aspirin may cause or worsen nosebleeds.
*'''Vascular abnormalities'''<ref name="KrulewitzFix2019">{{cite journal|last1=Krulewitz|first1=Neil Alexander|last2=Fix|first2=Megan Leigh|title=Epistaxis|journal=Emergency Medicine Clinics of North America|volume=37|issue=1|year=2019|pages=29–39|issn=07338627|doi=10.1016/j.emc.2018.09.005}}</ref> <ref name="DouglasWormald2007">{{cite journal|last1=Douglas|first1=Richard|last2=Wormald|first2=Peter-John|title=Update on epistaxis|journal=Current Opinion in Otolaryngology & Head and Neck Surgery|volume=15|issue=3|year=2007|pages=180–183|issn=1068-9508|doi=10.1097/MOO.0b013e32814b06ed}}</ref>
**[[Hereditary Hemorrhagic Telangiectasia]]
**Congestive hearth failure
**[[Granulomatosis with polyangitis]]
*'''Infections'''
*'''Coagulopathies:'''
**[[Anticoagulants]]
**[[Antiplatelet]]
**[[von Willebrand disease]]
**[[Leukemia]]
**Other [[medications]] causing [[coagulopathy]]
 
*[[Hypertension]] may be associated with [[epistaxis]]. A study has shown that incidence rates for [[epistaxis]] were significantly higher in the hypertensive patients, and they required [[posterior]] nasal packing more often than the control group (1.9% vs. 0.4%).<ref name="pmid32910190">{{cite journal| author=Byun H, Chung JH, Lee SH, Ryu J, Kim C, Shin JH| title=Association of Hypertension With the Risk and Severity of Epistaxis. | journal=JAMA Otolaryngol Head Neck Surg | year= 2020 | volume=  | issue=  | pages=  | pmid=32910190 | doi=10.1001/jamaoto.2020.2906 | pmc=7489409 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32910190  }} </ref>
 
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Needs content]]
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Otolaryngology]]
[[Category:Rhinology]]
[[Category:First aid]]
[[Category:Injuries]]

Latest revision as of 20:54, 11 January 2021

Epistaxis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Epistaxis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT Scan

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Epistaxis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Epistaxis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Epistaxis risk factors

CDC on Epistaxis risk factors

Epistaxis risk factors in the news

Blogs on Epistaxis risk factors

Directions to Hospitals Treating Epistaxis

Risk calculators and risk factors for Epistaxis risk factors


Editor in Chief: C. Michael Gibson, M.S., M.D. [[1]], Associate Editor(s)-in-Chief: Amir Behzad Bagheri, M.D. José Eduardo Riceto Loyola Junior, M.D.[1]

Overview

The most common risk factor of epistaxis is trauma. Other risk factors include coagulopathies, infections and vascular abnormalities. It can occur spontaneously. Childhood and senility are unchangeable risk factors.

Risk Factors

  • Hypertension may be associated with epistaxis. A study has shown that incidence rates for epistaxis were significantly higher in the hypertensive patients, and they required posterior nasal packing more often than the control group (1.9% vs. 0.4%).[4]

References

  1. Tunkel, David E.; Anne, Samantha; Payne, Spencer C.; Ishman, Stacey L.; Rosenfeld, Richard M.; Abramson, Peter J.; Alikhaani, Jacqueline D.; Benoit, Margo McKenna; Bercovitz, Rachel S.; Brown, Michael D.; Chernobilsky, Boris; Feldstein, David A.; Hackell, Jesse M.; Holbrook, Eric H.; Holdsworth, Sarah M.; Lin, Kenneth W.; Lind, Meredith Merz; Poetker, David M.; Riley, Charles A.; Schneider, John S.; Seidman, Michael D.; Vadlamudi, Venu; Valdez, Tulio A.; Nnacheta, Lorraine C.; Monjur, Taskin M. (2020). "Clinical Practice Guideline: Nosebleed (Epistaxis)". Otolaryngology–Head and Neck Surgery. 162 (1_suppl): S1–S38. doi:10.1177/0194599819890327. ISSN 0194-5998.
  2. Krulewitz, Neil Alexander; Fix, Megan Leigh (2019). "Epistaxis". Emergency Medicine Clinics of North America. 37 (1): 29–39. doi:10.1016/j.emc.2018.09.005. ISSN 0733-8627.
  3. Douglas, Richard; Wormald, Peter-John (2007). "Update on epistaxis". Current Opinion in Otolaryngology & Head and Neck Surgery. 15 (3): 180–183. doi:10.1097/MOO.0b013e32814b06ed. ISSN 1068-9508.
  4. Byun H, Chung JH, Lee SH, Ryu J, Kim C, Shin JH (2020). "Association of Hypertension With the Risk and Severity of Epistaxis". JAMA Otolaryngol Head Neck Surg. doi:10.1001/jamaoto.2020.2906. PMC 7489409 Check |pmc= value (help). PMID 32910190 Check |pmid= value (help).

Template:WikiDoc Sources